SEC
PBYI icon

Seven Eight Capital’s Puma Biotechnology PBYI Stock Holding History

Seven Eight Capital’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-35,132
Closed -$1.36M – 698
2019
Q1 		$1.36M Sell
35,132
-27,800
-44% -$849K 0.07% 312
2018
Q4 		$1.28M Buy
62,932
+1,296
+2% +$38.9K 0.07% 318
2018
Q3 		$2.83M Buy
+61,636
New +$2.97M 0.17% 181
2017
Q3 		– Sell
-13,809
Closed -$1.21M – 565
2017
Q2 		$1.21M Buy
+13,809
New +$772K 0.17% 183
2016
Q4 		– Sell
-33,400
Closed -$2.24M – 631
2016
Q3 		$2.24M Buy
+33,400
New +$1.69M 0.65% 43
2015
Q3 		– Sell
-1,000
Closed -$117K – 645
2015
Q2 		$117K Buy
+1,000
New +$181K 0.14% 243

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return